262 related articles for article (PubMed ID: 21914088)
21. Anti-inflammatory effect of peroxisome proliferator-activated receptor-γ (PPAR-γ) on non-obese diabetic mice with Sjogren's syndrome.
Li X; Xu B; Wang Y; Wei L
Int J Clin Exp Pathol; 2014; 7(8):4886-94. PubMed ID: 25197359
[TBL] [Abstract][Full Text] [Related]
22. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice.
Gatumu MK; Skarstein K; Papandile A; Browning JL; Fava RA; Bolstad AI
Arthritis Res Ther; 2009; 11(1):R24. PubMed ID: 19222863
[TBL] [Abstract][Full Text] [Related]
23. Chemokines Up-Regulated in Epithelial Cells Control Senescence-Associated T Cell Accumulation in Salivary Glands of Aged and Sjögren's Syndrome Model Mice.
Kurosawa M; Shikama Y; Furukawa M; Arakaki R; Ishimaru N; Matsushita K
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669065
[TBL] [Abstract][Full Text] [Related]
24. Disruption of endothelial barrier function is linked with hyposecretion and lymphocytic infiltration in salivary glands of Sjögren's syndrome.
Cong X; Zhang XM; Zhang Y; Wei T; He QH; Zhang LW; Hua H; Lee SW; Park K; Yu GY; Wu LL
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3154-3163. PubMed ID: 29981359
[TBL] [Abstract][Full Text] [Related]
25. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.
Nguyen CQ; Hu MH; Li Y; Stewart C; Peck AB
Arthritis Rheum; 2008 Mar; 58(3):734-43. PubMed ID: 18311793
[TBL] [Abstract][Full Text] [Related]
26. B7-H4 Inhibits the Development of Primary Sjögren's Syndrome by Regulating Treg Differentiation in NOD/Ltj Mice.
Zheng X; Wang Q; Yuan X; Zhou Y; Chu H; Wang G; Li X; Wang Y; Wei L; Wang L; Li X
J Immunol Res; 2020; 2020():4896727. PubMed ID: 33062721
[TBL] [Abstract][Full Text] [Related]
27. Effect of soluble ICAM-1 on a Sjögren's syndrome-like phenotype in NOD mice is disease stage dependent.
Roescher N; Vosters JL; Yin H; Illei GG; Tak PP; Chiorini JA
PLoS One; 2011 May; 6(5):e19962. PubMed ID: 21589878
[TBL] [Abstract][Full Text] [Related]
28. Catalpol ameliorates Sjögren's Syndrome by modulating interplay of T and B cells.
Lin R; Hao D; Dong Y; Wang Y
Biomed Pharmacother; 2020 Mar; 123():109806. PubMed ID: 31951976
[TBL] [Abstract][Full Text] [Related]
29. Human chorionic gonadotropin prevents Sjögren's syndrome-like exocrinopathy in mice.
Li N; Shigihara T; Tzioufas AG; Notkins AL; Yoon JW; Jun HS
Arthritis Rheum; 2007 Jul; 56(7):2211-5. PubMed ID: 17599739
[TBL] [Abstract][Full Text] [Related]
30. Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjögren's syndrome.
Kim DS; Woo JS; Min HK; Choi JW; Moon JH; Park MJ; Kwok SK; Park SH; Cho ML
J Autoimmun; 2021 May; 119():102611. PubMed ID: 33631650
[TBL] [Abstract][Full Text] [Related]
31. Two different types of sialoadenitis in the NOD- and MRL/lpr mouse models for Sjögren's syndrome: a differential role for dendritic cells in the initiation of sialoadenitis?
van Blokland SC; van Helden-Meeuwsen CG; Wierenga-Wolf AF; Drexhage HA; Hooijkaas H; van de Merwe JP; Versnel MA
Lab Invest; 2000 Apr; 80(4):575-85. PubMed ID: 10780673
[TBL] [Abstract][Full Text] [Related]
32. Pathogenic role of endogenous TNF-α in the development of Sjögren's-like sialadenitis and secretory dysfunction in non-obese diabetic mice.
Zhou J; Kawai T; Yu Q
Lab Invest; 2017 Apr; 97(4):458-467. PubMed ID: 28067896
[TBL] [Abstract][Full Text] [Related]
33. Non-depleting anti-CD4 antibody not only prevents onset but resolves sialadenitis in NOD mice.
Thompson C; Jacobsen H; Pomeranz Krummel D; Nagai K; Cooke A
Autoimmunity; 2004 Dec; 37(8):549-54. PubMed ID: 15763917
[TBL] [Abstract][Full Text] [Related]
34. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.
Cha S; Nagashima H; Brown VB; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 2002 May; 46(5):1390-8. PubMed ID: 12115247
[TBL] [Abstract][Full Text] [Related]
35. Sexual dimorphic function of IL-17 in salivary gland dysfunction of the C57BL/6.NOD-Aec1Aec2 model of Sjögren's syndrome.
Voigt A; Esfandiary L; Wanchoo A; Glenton P; Donate A; Craft WF; Craft SL; Nguyen CQ
Sci Rep; 2016 Dec; 6():38717. PubMed ID: 27958291
[TBL] [Abstract][Full Text] [Related]
36. NOD mouse model for Sjögren's syndrome: lack of longitudinal stability.
Lodde BM; Mineshiba F; Kok MR; Wang J; Zheng C; Schmidt M; Cotrim AP; Kriete M; Tak PP; Baum BJ
Oral Dis; 2006 Nov; 12(6):566-72. PubMed ID: 17054769
[TBL] [Abstract][Full Text] [Related]
37. Cytokines in Sjögren's syndrome.
Roescher N; Tak PP; Illei GG
Oral Dis; 2009 Nov; 15(8):519-26. PubMed ID: 19519622
[TBL] [Abstract][Full Text] [Related]
38. Effector mechanism of experimental autoimmune sialadenitis in the mouse model for primary Sjögren's syndrome.
Hayashi Y; Haneji N; Hamano H; Yanagi K; Takahashi M; Ishimaru N
Cell Immunol; 1996 Aug; 171(2):217-25. PubMed ID: 8806790
[TBL] [Abstract][Full Text] [Related]
39. Role of complement and B lymphocytes in Sjögren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2b mice.
Nguyen C; Cornelius J; Singson E; Killedar S; Cha S; Peck AB
Mol Immunol; 2006 Mar; 43(9):1332-9. PubMed ID: 16221495
[TBL] [Abstract][Full Text] [Related]
40. Activation of TLR9-dependent p38MAPK pathway in the pathogenesis of primary Sjögren's syndrome in NOD/Ltj mouse.
Shi H; Yu CQ; Xie LS; Wang ZJ; Zhang P; Zheng LY
J Oral Pathol Med; 2014 Nov; 43(10):785-91. PubMed ID: 25065264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]